Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease 18”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT03279523
What this trial is testing

F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected

Who this might be right for
Alzheimer DiseaseHIV
Tammie L. S. Benzinger, MD, PhD 60
Large-scale testing (Phase 3)Study completedNCT04526990
What this trial is testing

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Who this might be right for
COVID-19
CanSino Biologics Inc. 44,247
Testing effectiveness (Phase 2)Study completedNCT01518374
What this trial is testing

Clinical Evaluation of Florbetapir F 18 (18F-AV-45)

Who this might be right for
Alzheimer DiseaseMild Cognitive ImpairmentNeurodegenerative Diseases
Avid Radiopharmaceuticals 1,768
Large-scale testing (Phase 3)Study completedNCT01565382
What this trial is testing

Evaluation of Inter-reader Reliability Using Images From Subjects With Alzheimer's Disease (AD) or Mild Cognitive Impairment (MCI)

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 40
Testing effectiveness (Phase 2)Study completedNCT03919669
What this trial is testing

A Longitudinal Evaluation of a Radiotracer for Use in Tau Tracking

Who this might be right for
Alzheimer DiseaseMild Cognitive Impairment
University of Wisconsin, Madison 27
Not applicableStudy completedNCT02414282
What this trial is testing

F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)

Who this might be right for
Alzheimer DiseaseProgressive Posterior Cortical Dysfunction (PPCD)
Tammie L. S. Benzinger, MD, PhD 20
Not applicableLooking for participantsNCT07763392
What this trial is testing

Establishing Normal Cognitive Test Scores for Adults Using a Voice-Enabled Digital Testing Platform Across the Lifespan

Who this might be right for
CognitionCognition DisordersCognition - Other+4 more
The Neurology Center of Southern California 1,000
Not applicableStudy completedNCT01565369
What this trial is testing

Evaluation of Physician Training Methods to Read Florbetapir-PET Scans

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 35
Not applicableLooking for participantsNCT02414347
What this trial is testing

F 18 T807 Tau PET Imaging of Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Tammie L. S. Benzinger, MD, PhD 900
Early research (Phase 1)Study completedNCT02062099
What this trial is testing

PET Imaging of the Translocator Proteine Ligands (TSPO) With [18 F] DPA-714 Biomarker of NeuroInflammation in Cognitive Decline (NIDECO)

Who this might be right for
Memory ComplaintMild Cognitive ImpairmentAlzheimer Disease
University Hospital, Tours 25
Large-scale testing (Phase 3)Study completedNCT01447719
What this trial is testing

Autopsy Follow-up of Subjects Previously Imaged With Florbetapir F 18 (18F-AV-45) PET in Trial 18F-AV-45-A07

Who this might be right for
Alzheimer's Disease
Avid Radiopharmaceuticals 110
Testing effectiveness (Phase 2)Study completedNCT02813070
What this trial is testing

Comparison of PET Amyloid Imaging in Japanese and Western Subjects

Who this might be right for
Mild Cognitive ImpairmentAlzheimer's DiseaseHealthy
GE Healthcare 70
Post-approval studies (Phase 4)Study completedNCT02553928
What this trial is testing

Comparison of Once Daily and Twice Daily Dosing on Safety and Tolerability of Memantine in Patients With Alzheimer

Who this might be right for
Alzheimer Dementia (AD)
H. Lundbeck A/S 62
Testing effectiveness (Phase 2)Active Not RecruitingNCT05531656
What this trial is testing

Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

Who this might be right for
Early Alzheimer's Disease
Cognition Therapeutics 540
Testing effectiveness (Phase 2)Study completedNCT03467477
What this trial is testing

Tau Screening Study in Subjects With Early Symptomatic AD

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 161
Testing effectiveness (Phase 2)Study completedNCT00857506
What this trial is testing

Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45)

Who this might be right for
Alzheimer's DiseaseMild Cognitive Impairment
Avid Radiopharmaceuticals 152
Post-approval studies (Phase 4)Active Not RecruitingNCT01606488
What this trial is testing

Effects of Brain Beta-Amyloid on Postoperative Cognition

Who this might be right for
Postoperative Cognitive Dysfunction
University of California, San Francisco 66
Not applicableWithdrawnNCT04100889
What this trial is testing

A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Alzheimer's Disease

Who this might be right for
Alzheimer DiseaseAlzheimer Disease 1Alzheimer Disease 2+20 more
ProgenaBiome
Not applicableUnknownNCT02802371
What this trial is testing

Pharmaceutical Collaborative Care Integrated to a Multidisciplinary Psychosocial Program

Who this might be right for
Alzheimer Disease
Hospices Civils de Lyon 240
Large-scale testing (Phase 3)Study completedNCT03901092
What this trial is testing

A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation

Who this might be right for
Alzheimer Disease
Avid Radiopharmaceuticals 242
Next Page